spacer
The Healthcare Sales & Marketing Network celebrates 27 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  postsurgical pain 

 HSMN NewsFeed - 13 May 2021
Heron Therapeutics Announces U.S. FDA Approval of ZYNRELEF(TM) (HTX-011) for the Management of Postoperative Pain for up to 72 Hours
Biopharmaceuticals FDA
 HSMN NewsFeed - 2 Feb 2021
DURECT Corporation Announces U.S. FDA Approval of POSIMIR(R) For Post-Surgical Pain Reduction for up to 72 Hours Following Arthroscopic Subacromial Decompression
Biopharmaceuticals Drug Delivery FDA
 HSMN NewsFeed - 31 Dec 2018
FDA Grants Priority Review Designation for Heron Therapeutics' NDA for HTX-011, a Non-Opioid for Postoperative Pain Management
Biopharmaceuticals Surgery FDA
 HSMN NewsFeed - 25 Jan 2017
DePuy Synthes Announces Exclusive Co-Promotional Agreement with Pacira Pharmaceuticals, Inc.
Devices Orthopaedic Distribution
 HSMN NewsFeed - 30 Dec 2016
Innocoll Receives Refusal to File Letter from U.S. FDA for XARACOLL(R) (bupivacaine HCl collagen-matrix implants) New Drug Application
Biopharmaceuticals Drug Delivery FDA
 HSMN NewsFeed - 1 Feb 2016
Mallinckrodt Completes Acquisition Of Three Commercial-Stage, Global Specialty Hemostasis Brands From The Medicines Company
Devices Surgery Acquisitions
 HSMN NewsFeed - 19 Mar 2014
Mallinckrodt plc Completes $1.4 Billion Acquisition of Cadence Pharmaceuticals, Inc.
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 11 Feb 2014
Mallinckrodt plc to Acquire Cadence Pharmaceuticals, Inc. for $14.00 Per Share, in Cash
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 29 May 2013
Pacira Pharmaceuticals, Inc. Announces Positive Interim Analysis of EXPAREL in Femoral Nerve Block for Total Knee Arthroplasty
Biopharmaceuticals
 HSMN NewsFeed - 31 Oct 2011
Pacira Pharmaceuticals, Inc. Announces U.S. FDA Approval of EXPAREL(TM) For Postsurgical Pain Management
Biopharmaceuticals FDA
 HSMN NewsFeed - 6 Aug 2008
Pacira Pharmaceuticals, Inc. Adds Experienced CFO James S. Scibetta to Leadership of the Organization
Biopharmaceuticals Personnel
 HSMN NewsFeed - 31 Jul 2008
Javelin Pharmaceuticals and Baxter Healthcare Corporation Expand Commercial Supply Relationship for Anticipated Dyloject(TM) Global Growth
Biopharmaceuticals
 HSMN NewsFeed - 9 Jul 2008
Pacira Pharmaceuticals, Inc. Adds Board Member and Key Senior Management
Biopharmaceuticals Personnel
 HSMN NewsFeed - 10 Mar 2008
Javelin Pharmaceuticals' Dyloject Accepted by Scottish Medicines Consortium (SMC)
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 22 May 2007
Javelin Pharmaceuticals Signs Commercial Supply Agreement with Baxter Healthcare Corporation
Biopharmaceuticals
 HSMN NewsFeed - 12 Sep 2006
Javelin Pharmaceuticals, Inc. To Present Final Analysis of Phase 2b Study Results of Dyloject(TM) at Prestigious European Pain Conference - September 14, 2006
Biopharmaceuticals
Return to NewsFeed  

 Additional items found! 4

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 4 additional stories matching:
postsurgical pain
(Password required)
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.